Back to Search

AUPH

Aurinia Pharmaceuticals Inc
Data: 2026-10-02
$15.83
Price
-0.75%
Change
$19.25
52W High
$10.90
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options
Analyzing positioning… Options positioning — based on yesterday's biggest open-interest changes See the chart Institutional flows
Track record
signal day → next-day price move
Quick Stats
Oct 02, 2026

49.4

AI Score

HOLD

0.92

Volume Ratio

Nov 03, 2026

Next Earnings

8

+ve Days (30d)

21

-ve Days (30d)

AUPH Price vs Max Options Open Interest

How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.

AUPH Max Change In Options Open Interest

How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.

AUPH Options - Sort by Max open Interest (near term)

3rd October 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

AUPH Daily Out of Money Options - Sort by Max open Interest (near term)

3rd October 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

AUPH Daily In the Money Options - Sort by Max open Interest (near term)

3rd October 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

AUPH Most Active Options by Volume(near term)

3rd October 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track
AUPH Technical Chart Pro Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select an indicator above — it will be added as a pane under the price chart with aligned dates.

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

AUPH Stock Summary

Last updated Oct 02, 2026

AUPH is currently trading at $15.83, positioned above its 200-day moving average of $15.56, indicating a long-term uptrend. The stock has a 52-week range of $10.9016 to $19.25.

Technical Analysis: The 50-day moving average stands at $15.99, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 40.966, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.047, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates AUPH at 49.4/100 with a HOLD recommendation.

AUPH (Aurinia Pharmaceuticals Inc) Indicators

Last updated Oct 02, 2026

Indicator Value
RSI(14) 40.966
CMF (20) -0.047
ROC (10) -6.331
ADX (14) 22.809
Indicator Value
MACD (12,26,9) -0.005
AROONOSC (14) -78.571
WILLAMS %R (14) -93.662
MFI (14) 17.052

AUPH Candlestick Patterns

Validated patterns fired in the last 10 sessions. Hit rate = how often price moved in the signal's direction within 5 trading days (backtest: 2.7M signals, 3,500 liquid stocks, Feb 2025–Sep 2026). Baseline: a random stock closes higher 5 days later 53% of the time. Click a row to see the candle on the chart.

Date Pattern Signal 5-Day Hit Rate Edge vs Baseline Sample
Sep 30 Marubozu (bearish) (contrarian — textbook says the opposite) Bullish 56.2% +3.2 pts 30540

These are statistical tilts, not standalone trade setups. Only patterns with a measured edge are shown — roughly 50 of 60 textbook patterns showed no edge and are hidden.

Aurinia Pharmaceuticals Inc is above the 200 Day SMA but below the 50 Day SMA — long-term uptrend intact but under near-term pressure (Mixed).

AUPH Moving Averages Analysis

Aurinia Pharmaceuticals Inc has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Oct 02, 2026

AUPH (Aurinia Pharmaceuticals Inc) Simple Moving Averages

Moving Averages are last updated Oct 02, 2026

Days MA
10 16.36
20 16.38
30 16.38
50 15.99
100 16.0
200 15.56

AUPH Fundamental Analysis

P/E (Forward) 11.8343
P/E (Trailing) 6.9956
Market Cap ($) 2.1 billion
Earnings/Share ($) 2.28
Net Profit Margin (%) 1.0084
Dividend/Share ($) --
EPS Estimate Current Year ($) 0.944
EPS Estimate Next Year ($) 1.0667
WallStreet Target Price ($) 17.86
Most Recent Quarter

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.